Mainstream

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline

Post ContentfgenRead More

You might also be interested in reading Bitcoin rewards app Lolli closes $10M investment round.

May 13, 2025
In Mainstream